|
Virtual Interactive 3D Modelling to Improve Outcomes in Robotic-Assisted Partial Nephrectomy
RECRUITINGN/ASponsored by University of Leipzig
Actively Recruiting
PhaseN/A
SponsorUniversity of Leipzig
Started2023-10-24
Est. completion2026-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06056505
Summary
The primary objective is to determine if 3D modelling shortens total console operation time as a surrogate endpoint for clinical outcomes like perioperative complications and morbidity in robotic-assisted partial nephrectomy.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * Patients with kidney tumours ≤ 7cm and planned robotic-assisted partial nephrectomy with the DaVinci Surgical System * CT scan with contrast medium available * Age ≥ 18 years * Written informed consent Exclusion Criteria: * History of surgery on affected kidney (e.g., partial nephrectomy, pyeloplasty, kidney cyst deroofing, percutaneous nephrolitholapaxy, radiofrequency ablation) * Horseshoe kidney * Previous malignancy with ongoing or planned nephrotoxic chemotherapy * Patient is immunosuppressed (e.g., organ transplantation, leukaemia) * Tumor thrombus in Vena renalis or Vena cava inferior * Existing renal insufficiency GFR \< 15 ml/min/1.73m2 * Severe cognitive impairment * Pregnancy or lactation or women with desire for children * Patients under legal supervision or guardianship * Unable to give informed consent or suspected lack of compliance * Patients who refuse to data collection and storage for the main study
Conditions2
CancerKidney Tumor
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorUniversity of Leipzig
Started2023-10-24
Est. completion2026-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT06056505